Primary Hepatic Squamous Cell Carcinoma With High Microsatellite Instability Shows Good Response to Programmed Cell Death 1 Inhibitor as Adjuvant Therapy.

MLA

Wang, Ke, et al. “Primary Hepatic Squamous Cell Carcinoma With High Microsatellite Instability Shows Good Response to Programmed Cell Death 1 Inhibitor as Adjuvant Therapy.” Hepatology (Baltimore, Md.), vol. 74, no. 3, Sept. 2021, pp. 1695–97. EBSCOhost, https://doi.org/10.1002/hep.31737.

APA

Wang, K., Lu, C. D., Sun, J. N., Wang, C. N., Gao, G., Hu, Y. K., Zhang, H. Z., Zhang, D., & Wu, S. D. (2021). Primary Hepatic Squamous Cell Carcinoma With High Microsatellite Instability Shows Good Response to Programmed Cell Death 1 Inhibitor as Adjuvant Therapy. Hepatology (Baltimore, Md.), 74(3), 1695–1697. https://doi.org/10.1002/hep.31737

Chicago

Wang, Ke, Cai De Lu, Jian Nan Sun, Chun Nian Wang, Guo Gao, Yang Ke Hu, Hui Zhi Zhang, Ding Zhang, and Sheng Dong Wu. 2021. “Primary Hepatic Squamous Cell Carcinoma With High Microsatellite Instability Shows Good Response to Programmed Cell Death 1 Inhibitor as Adjuvant Therapy.” Hepatology (Baltimore, Md.) 74 (3): 1695–97. doi:10.1002/hep.31737.